Clinical Trial Update: Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating a gastrin-17-diphtheria toxoid vaccine (G17DT) in combination with irinotecan in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• G17DT
• Irinotecan (Irinotecan)

Snippet

Sponsor: Cancer Advances Inc. | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED